Dr. Manzoor Ahmad Tariq, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1071 Airport Road, Festus, MO 63028 Phone: 636-931-7111 Fax: 636-937-7486 |
Dr. Bassam A. Roukoz, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1390 Highway 61, Suite 3300, Festus, MO 63028 Phone: 636-931-6302 Fax: 636-931-3609 |
Dr. Jeffrey T Reese, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1390 Highway 61, Suite 3300, Festus, MO 63028 Phone: 636-931-6302 Fax: 636-933-3609 |
News Archive
Did you know multiple sclerosis (MS) means multiple scars? New research shows that the brain and spinal cord scars in people with MS may offer clues to why they developprogressive disability but those with related diseases where the immune system attacks the central nervous system do not.
Bristol-Myers Squibb Company is commencing today, through its wholly owned subsidiary Zeus Acquisition Corporation, a cash tender offer to purchase all outstanding shares of common stock of ZymoGenetics, Inc.. Bristol-Myers Squibb announced on Tuesday, September 7, 2010 its intent to acquire ZymoGenetics.
Aruba Networks, Inc., a global leader in distributed enterprise network solutions, today announced that Thailand's Khon Kaen University Faculty of Medicine has deployed its adaptive Wi-Fi networks and AirWave Wireless Management System to support X-Ray image archiving, healthcare and drug dosage record access, and Internet access to 2,000 staff members and 1,200 students. The new system replaces legacy Cisco and 3COM autonomous FAT access points, and was deployed by Aruba authorized partner World Information Technology Company.
Cancer remains the second-leading cause of death in the United States. This year, an estimated 1.7 million new cases will be diagnosed, with nearly 610,000 people expected to die from the disease, according to the National Cancer Institute.
In a large population of Medicare beneficiaries with heart failure who underwent implantation of a cardiac resynchronization therapy defibrillator, patients who had the cardiac characteristics of left bundle-branch block and longer QRS duration had the lowest risks of death and all-cause, cardiovascular, and heart failure readmission, according to a study in the August 14 issue of JAMA
› Verified 6 days ago